Showing 461-470 of 994 results for "".
- Global Botulinum Toxins Market Projected to Reach $15.7 Billion by 2030https://modernaesthetics.com/news/global-botulinum-toxins-market-projected-to-reach-157-billion-by-2030/2475785/The global market for botulinum toxin products is expected to grow from $8.9 billion in 2025 to $15.7 billion by 2030, according to new projections from MarketsandMarkets, representing a compound annual growth rate (CAGR) of 11.7%. This sustained growth is attributed to increased global de
- Galderma Establishes new US Headquarters in Florida to Strengthen Regional Leadershiphttps://modernaesthetics.com/news/galderma-establishes-new-us-headquarters-in-florida-to-strengthen-regional-leadership/2475385/Galderma announced Tuesday the company is establishing a new US headquarters in Miami, Florida. The new location aims to position Galderma at the heart of a thriving market for Dermatological Skincare and Injectable Aesthetics. The headquarter will be in the Brickell neighborhood
- GALDA Co-Director Explains Organization's Work and Impacthttps://modernaesthetics.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- 2025 SCALE: Enhancing Injection Safety and Precision with Ultrasound Guidancehttps://modernaesthetics.com/news/2025-scale-enhancing-injection-safety-and-precision-with-ultrasound-guidance/2475379/At the 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Benjamin Ascher, MD, gave a lecture titled “Why Injections Under Ultrasound Guide Are Crucial in Aesthetic Medicine.” Dr. Ascher explained shifts in facial injection practices,
- Dr. Sebastian Cotofana Shares Unpublished Research Targeting Glabellar Lines with Neurotoxins at SCALEhttps://modernaesthetics.com/news/dr-sebastian-cotofana-shares-unpublished-research-targeting-glabellar-lines-with-neurotoxins-at-scale/2475377/The 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE) was held from May 14 to 18 at the Grand Hyatt in Nashville, Tennessee. The agenda included an update on neurotoxin related to facial anatomy for improved aesthetic outcomes from Seb
- Analysis: PBoNT/A and ABoNT/A Show Fastest Onset in Glabellar Line Treatmenthttps://modernaesthetics.com/news/analysis-pbonta-and-abonta-show-fastest-onset-in-glabellar-line-treatment/2475374/A newly published study reports the comparative effects of four botulinum toxin A (BoNT/A) formulations on glabellar strain, with observed differences in onset, longevity, and muscular strain patterns.
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glu
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum to
- Evolus Launches “Drop the F Word” Campaign Ahead of Evolysse Injectable HA Gelshttps://modernaesthetics.com/news/evolus-launches-drop-the-f-word-campaign-ahead-of-evolysse-injectable-ha-gels/2475348/Evolus, Inc. rolled out a new campaign, “Drop the F Word,” ahead of the upcoming commercial launch of EvolysseTM injectable hyaluronic acid gels. The campaign aims to challenge outdated perceptions and language in the aesthetics industry, according to a press release,
- Global Experts Urge Return to ‘Natural Breast Beauty’ Amid Rise in Aesthetic Complicationshttps://modernaesthetics.com/news/global-experts-urge-return-to-natural-breast-beauty-amid-rise-in-aesthetic-complications/2475346/In response to rising rates of revision surgery and dissatisfaction with overly augmented results, an international coalition of leading plastic surgeons has introduced new framework for achieving more natural outcomes in breast augmentation. The Global Consensus on Natural Breast